208 related articles for article (PubMed ID: 18412239)
1. Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.
Applegate RJ; Sacrinty M; Kutcher M; Santos R; Gandhi S; Little W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):7-12. PubMed ID: 18412239
[TBL] [Abstract][Full Text] [Related]
2. Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.
Gioia G; Benassi A; Mohendra R; Chowdhury K; Masood I; Matthai W
Catheter Cardiovasc Interv; 2008 Jul; 72(1):13-20. PubMed ID: 18561143
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis.
Sanchez-Recalde A; Jiménez Valero S; Moreno R; Barreales L; Lozano I; Galeote G; Martín Reyes R; Calvo L; Lopez-Sendon JL
EuroIntervention; 2010 May; 6(1):149-60. PubMed ID: 20542811
[TBL] [Abstract][Full Text] [Related]
5. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).
Vignali L; Saia F; Manari A; Santarelli A; Rubboli A; Varani E; Piovaccari G; Menozzi A; Percoco G; Benassi A; Rusticali G; Marzaroli P; Guastaroba P; Grilli R; Maresta A; Marzocchi A
Am J Cardiol; 2008 Apr; 101(7):947-52. PubMed ID: 18359313
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical benefit of sirolimus-eluting stents compared to bare metal stents in the treatment of saphenous vein graft disease.
Minutello RM; Bhagan S; Sharma A; Slotwiner AJ; Feldman DN; Cuomo LJ; Wong SC
J Interv Cardiol; 2007 Dec; 20(6):458-65. PubMed ID: 18042050
[TBL] [Abstract][Full Text] [Related]
8. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes.
Applegate RJ; Sacrinty MT; Kutcher MA; Santos RM; Gandhi SK; Little WC
Circ Cardiovasc Interv; 2009 Feb; 2(1):35-42. PubMed ID: 20031691
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous intervention on the saphenous vein bypass grafts--long-term outcomes.
Bansal D; Muppidi R; Singla S; Sukhija R; Zarich S; Mehta JL; Sachdeva R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):58-61. PubMed ID: 18098183
[TBL] [Abstract][Full Text] [Related]
11. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of drug-eluting and bare metal stents in saphenous vein grafts. Immediate and long-term results].
Lozano I; García-Camarero T; Carrillo P; Baz JA; de la Torre JM; López-Palop R; Pinar E; Salvatella N; Avanzas P; Valdés M
Rev Esp Cardiol; 2009 Jan; 62(1):39-47. PubMed ID: 19150013
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting versus bare-metal stents for treating saphenous vein grafts.
Shishehbor MH; Hawi R; Singh IM; Tuzcu EM; Bhatt DL; Ellis SG; Kapadia SR
Am Heart J; 2009 Oct; 158(4):637-43. PubMed ID: 19781425
[TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels.
Quizhpe AR; Feres F; de Ribamar Costa J; Abizaid A; Maldonado G; Costa R; Abizaid A; Cano M; Moreira AC; Staico R; Mattos LA; Tanajura LF; Chaves A; Centemero M; Sousa AM; Sousa JE
Am Heart J; 2007 Aug; 154(2):373-8. PubMed ID: 17643591
[TBL] [Abstract][Full Text] [Related]
15. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention.
Roy P; Buch AN; Javaid A; Okabe T; Raya V; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2008 Feb; 101(3):293-9. PubMed ID: 18237587
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
17. Two-year clinical outcomes following elective drug-eluting versus bare-metal stent implantation: results from a large single-center database.
Gao RL; Xu B; Chen JL; Yang YJ; Qiao SB; Wang Y; Dou KF; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Ma WH; Li W
Chin Med J (Engl); 2009 Oct; 122(19):2261-7. PubMed ID: 20079124
[TBL] [Abstract][Full Text] [Related]
18. Comparison of long-term outcomes of bare metal or drug-eluting stent implantation in standard versus off-label coronary narrowings.
Harjai KJ; Orshaw P; Boura J; Sporn D
Am J Cardiol; 2009 Jun; 103(11):1537-45. PubMed ID: 19463512
[TBL] [Abstract][Full Text] [Related]
19. Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET.
Pfisterer M; Brunner-La Rocca HP; Rickenbacher P; Hunziker P; Mueller C; Nietlispach F; Leibundgut G; Bader F; Kaiser C;
Eur Heart J; 2009 Jan; 30(1):16-24. PubMed ID: 19033260
[TBL] [Abstract][Full Text] [Related]
20. Utility of sirolimus-eluting Cypher stents to reduce 12-month target vessel revascularization in saphenous vein graft stenoses: results of a multicenter 350-patient case-control study.
Ellis SG; Kandzari D; Kereiakes DJ; Pichard A; Huber K; Resnic F; Yakubov S; Callahan K; Borgman M; Cohen SA
J Invasive Cardiol; 2007 Oct; 19(10):404-9. PubMed ID: 17906340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
